Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3962)
All Articles published online
|
Feb 6, 2012 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yanai A, Sakamoto K, Akanuma M, Ogura K, Maeda S. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. World J Gastrointest Pharmacol Ther 2012; 3(1): 1-6 [PMID: 22408744 DOI: 10.4292/wjgpt.v3.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v3/i1/1.htm |
| Number | Citing Articles |
| 1 |
Javier Molina-Infante, David Y. Graham. Helicobacter pylori Research. 2016; : 471 doi: 10.1007/978-4-431-55936-8_20
|
| 2 |
Richard J.M. Ingram, Krish Ragunath, John C. Atherton. Yamada' s Textbook of Gastroenterology. 2015; : 1032 doi: 10.1002/9781118512074.ch56
|
| 3 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2016; 39(10): 697 doi: 10.1016/j.gastrohep.2016.05.003
|
| 4 |
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
|
| 5 |
Bojan Tepes, Anthony O'Connor, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2012. Helicobacter 2012; 17(s1): 36 doi: 10.1111/j.1523-5378.2012.00981.x
|
| 6 |
Chi-Tan Hu. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions. Tzu Chi Medical Journal 2022; 34(3): 303 doi: 10.4103/tcmj.tcmj_185_21
|
| 7 |
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infection. World Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
|
| 8 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2016; 39(10): 697 doi: 10.1016/j.gastre.2016.11.007
|
| 9 |
Jason Ferreira, Steven F. Moss. Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection. Current Treatment Options in Gastroenterology 2014; 12(4): 373 doi: 10.1007/s11938-014-0027-6
|
| 10 |
Hassan Seddik, Samir Ahid, Tarek El Adioui, Fatim-Zohra El Hamdi, Mohammed Hassar, Redouane Abouqal, Yahia Cherrah, Ahmed Benkirane. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study. European Journal of Clinical Pharmacology 2013; 69(9): 1709 doi: 10.1007/s00228-013-1524-6
|
| 11 |
Hassan Ali Metanat, Seyed Mohammad Valizadeh, Hafez Fakheri, Iradj Maleki, Tarang Taghvaei, Vahid Hosseini, Zohreh Bari. Comparison Between 10‐ and 14‐Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial. Helicobacter 2015; 20(4): 299 doi: 10.1111/hel.12202
|
| 12 |
Javier Molina-Infante, Akiko Shiotani. Practical Aspects in Choosing a Helicobacter pylori Therapy. Gastroenterology Clinics of North America 2015; 44(3): 519 doi: 10.1016/j.gtc.2015.05.004
|
| 13 |
|
| 14 |
Theodore Rokkas, Javier P. Gisbert, Peter Malfertheiner, Yaron Niv, Antonio Gasbarrini, Marcis Leja, Francis Megraud, Colm O’Morain, David Y. Graham. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology 2021; 161(2): 495 doi: 10.1053/j.gastro.2021.04.012
|
| 15 |
Fernando Macías‐García, Iria Bastón‐Rey, Daniel de la Iglesia‐García, Cristina Calviño‐Suárez, Laura Nieto‐García, Juan Enrique Domínguez‐Muñoz. Bismuth‐containing quadruple therapy versus concomitant quadruple therapy as first‐line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross‐sectional, comparative, open trial. Helicobacter 2019; 24(1) doi: 10.1111/hel.12546
|
| 16 |
Javier Molina-Infante, Javier P Gisbert. Optimizing clarithromycin-containing therapy for <italic>Helicobacter pylori</italic> in the era of antibiotic resistance. World Journal of Gastroenterology 2014; 20(30): 10338-10347 doi: 10.3748/wjg.v20.i30.10338
|
| 17 |
Anthony O'Connor, Javier Molina‐Infante, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori Infection 2013. Helicobacter 2013; 18(s1): 58 doi: 10.1111/hel.12075
|
| 18 |
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research. 2016; : 519 doi: 10.1007/978-4-431-55936-8_23
|
| 19 |
Yoen‐Young Chuah, Deng‐Chyang Wu, Seng‐Kee Chuah, Jyh‐Chin Yang, Tzong‐Hsi Lee, Hong‐Zen Yeh, Chan‐Lin Chen, Yu‐Hwa Liu, Ping‐I Hsu. Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey). Helicobacter 2017; 22(3) doi: 10.1111/hel.12380
|
| 20 |
Shachish Doctor, Philip Abraham, Devendra Desai, Pavan Dhoble, Tarun Gupta, Anand Joshi. Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance rates. Indian Journal of Gastroenterology 2022; 41(6): 627 doi: 10.1007/s12664-022-01272-1
|
| 21 |
Xin Yan Zhu, Fei Liu. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. Journal of Digestive Diseases 2017; 18(4): 195 doi: 10.1111/1751-2980.12466
|
| 22 |
Ala I Sharara, Fayez S Sarkis, Mustapha M El-Halabi, Ahmad Malli, Nabil M Mansour, Cecilio Azar, Mohamad A Eloubeidi, Fadi H Mourad, Kassem Barada, Ismail Sukkarieh. Challenging the dogma: a randomized trial of standard vs. half‐dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection. United European Gastroenterology Journal 2014; 2(3): 179 doi: 10.1177/2050640614530919
|
| 23 |
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective. Molecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
|
| 24 |
Yasser Abu-Safieh, Hanin Yamin. Sequential and concomitant non-bismuth quadruple therapies are ineffective for <i>H. pylori</i> eradication in Palestine. A randomized trial. Open Journal of Gastroenterology 2012; 2(04): 177 doi: 10.4236/ojgas.2012.24034
|
| 25 |
Kosuke Sakitani, Yoshihiro Hirata, Nobumi Suzuki, Satoki Shichijo, Ayako Yanai, Takako Serizawa, Kei Sakamoto, Masao Akanuma, Shin Maeda, Yutaka Yamaji, Yasuhiko Iwamoto, Shoji Kawazu, Kazuhiko Koike. Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0377-0
|